aluates Reports

$ 0.0

Automative

Global Long-acting Weight Loss Drugs Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-9H16447

Global Long acting Weight Loss Drugs Market Research Report 2023

BUY CHAPTERS

Global Long-acting Weight Loss Drugs Market Research Report 2025

Code: QYRE-Auto-9H16447

Report

June 2025

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novo Nordisk

Roche

GSK

VIVUS

Arena

Orexigen

Long-acting Weight Loss Drugs Market Size

The global market for Long-acting Weight Loss Drugs was valued at US$ 4675 million in the year 2024 and is projected to reach a revised size of US$ 7173 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Long-acting Weight Loss Drugs Market

Long-acting weight loss drugs, also known as extended-release or sustained-release weight loss medications, are pharmaceuticals designed to help individuals manage their weight by reducing appetite, increasing feelings of fullness, or altering the body"s metabolism over an extended period. These drugs are formulated to provide more sustained effects, allowing for less frequent dosing. It"s essential to note that these medications are typically prescribed under the guidance of a healthcare professional and are intended for use as part of a comprehensive weight management program.

The market for long-acting weight loss drugs is experiencing rapid growth, driven by global concerns about obesity and an ongoing pursuit of healthy lifestyles. The market size has significantly expanded, with increasing sales. The specific uses of long-acting weight loss drugs primarily involve assisting individuals who struggle to achieve their ideal weight through traditional methods. These drugs work by regulating appetite, promoting metabolism, or affecting energy absorption to achieve long-term weight loss. In the future, with ongoing technological innovations and an increasing awareness of health, the development and application of long-acting weight loss drugs are expected to continue progressing, offering more solutions to the global obesity issue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Long-acting Weight Loss Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting Weight Loss Drugs.

The Long-acting Weight Loss Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-acting Weight Loss Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Long-acting Weight Loss Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Long-acting Weight Loss Drugs Market Report

Report Metric	Details
Report Name	Long-acting Weight Loss Drugs Market
Accounted market size in year	US$ 4675 million
Forecasted market size in 2031	US$ 7173 million
CAGR	6.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Orlistat Semaglutide Liraglutide Other
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novo Nordisk, Roche, GSK, Vivus, Arena, Orexigen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Long-acting Weight Loss Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Long-acting Weight Loss Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Long-acting Weight Loss Drugs Market growing?

Ans: The Long-acting Weight Loss Drugs Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Long-acting Weight Loss Drugs Market size in 2031?

Ans: The Long-acting Weight Loss Drugs Market size in 2031 will be US$ 7173 million.

Who are the main players in the Long-acting Weight Loss Drugs Market report?

Ans: The main players in the Long-acting Weight Loss Drugs Market are Novo Nordisk, Roche, GSK, Vivus, Arena, Orexigen

What are the Application segmentation covered in the Long-acting Weight Loss Drugs Market report?

Ans: The Applications covered in the Long-acting Weight Loss Drugs Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Long-acting Weight Loss Drugs Market report?

Ans: The Types covered in the Long-acting Weight Loss Drugs Market report are Orlistat, Semaglutide, Liraglutide, Other

1 Long-acting Weight Loss Drugs Market Overview

1.1 Product Definition

1.2 Long-acting Weight Loss Drugs by Type

1.2.1 Global Long-acting Weight Loss Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Orlistat

1.2.3 Semaglutide

1.2.4 Liraglutide

1.2.5 Other

1.3 Long-acting Weight Loss Drugs by Application

1.3.1 Global Long-acting Weight Loss Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Long-acting Weight Loss Drugs Market Size Estimates and Forecasts

1.4.1 Global Long-acting Weight Loss Drugs Revenue 2020-2031

1.4.2 Global Long-acting Weight Loss Drugs Sales 2020-2031

1.4.3 Global Long-acting Weight Loss Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Long-acting Weight Loss Drugs Market Competition by Manufacturers

2.1 Global Long-acting Weight Loss Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Long-acting Weight Loss Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Long-acting Weight Loss Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Long-acting Weight Loss Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Long-acting Weight Loss Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Long-acting Weight Loss Drugs, Product Type & Application

2.7 Global Key Manufacturers of Long-acting Weight Loss Drugs, Date of Enter into This Industry

2.8 Global Long-acting Weight Loss Drugs Market Competitive Situation and Trends

2.8.1 Global Long-acting Weight Loss Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Long-acting Weight Loss Drugs Players Market Share by Revenue

2.8.3 Global Long-acting Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Long-acting Weight Loss Drugs Market Scenario by Region

3.1 Global Long-acting Weight Loss Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Long-acting Weight Loss Drugs Sales by Region: 2020-2031

3.2.1 Global Long-acting Weight Loss Drugs Sales by Region: 2020-2025

3.2.2 Global Long-acting Weight Loss Drugs Sales by Region: 2026-2031

3.3 Global Long-acting Weight Loss Drugs Revenue by Region: 2020-2031

3.3.1 Global Long-acting Weight Loss Drugs Revenue by Region: 2020-2025

3.3.2 Global Long-acting Weight Loss Drugs Revenue by Region: 2026-2031

3.4 North America Long-acting Weight Loss Drugs Market Facts & Figures by Country

3.4.1 North America Long-acting Weight Loss Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Long-acting Weight Loss Drugs Sales by Country (2020-2031)

3.4.3 North America Long-acting Weight Loss Drugs Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Long-acting Weight Loss Drugs Market Facts & Figures by Country

3.5.1 Europe Long-acting Weight Loss Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Long-acting Weight Loss Drugs Sales by Country (2020-2031)

3.5.3 Europe Long-acting Weight Loss Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Long-acting Weight Loss Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Long-acting Weight Loss Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Long-acting Weight Loss Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Long-acting Weight Loss Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Long-acting Weight Loss Drugs Market Facts & Figures by Country

3.7.1 Latin America Long-acting Weight Loss Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Long-acting Weight Loss Drugs Sales by Country (2020-2031)

3.7.3 Latin America Long-acting Weight Loss Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Long-acting Weight Loss Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Long-acting Weight Loss Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Long-acting Weight Loss Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Long-acting Weight Loss Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Long-acting Weight Loss Drugs Sales by Type (2020-2031)

4.1.1 Global Long-acting Weight Loss Drugs Sales by Type (2020-2025)

4.1.2 Global Long-acting Weight Loss Drugs Sales by Type (2026-2031)

4.1.3 Global Long-acting Weight Loss Drugs Sales Market Share by Type (2020-2031)

4.2 Global Long-acting Weight Loss Drugs Revenue by Type (2020-2031)

4.2.1 Global Long-acting Weight Loss Drugs Revenue by Type (2020-2025)

4.2.2 Global Long-acting Weight Loss Drugs Revenue by Type (2026-2031)

4.2.3 Global Long-acting Weight Loss Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Long-acting Weight Loss Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Long-acting Weight Loss Drugs Sales by Application (2020-2031)

5.1.1 Global Long-acting Weight Loss Drugs Sales by Application (2020-2025)

5.1.2 Global Long-acting Weight Loss Drugs Sales by Application (2026-2031)

5.1.3 Global Long-acting Weight Loss Drugs Sales Market Share by Application (2020-2031)

5.2 Global Long-acting Weight Loss Drugs Revenue by Application (2020-2031)

5.2.1 Global Long-acting Weight Loss Drugs Revenue by Application (2020-2025)

5.2.2 Global Long-acting Weight Loss Drugs Revenue by Application (2026-2031)

5.2.3 Global Long-acting Weight Loss Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Long-acting Weight Loss Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Novo Nordisk

6.1.1 Novo Nordisk Company Information

6.1.2 Novo Nordisk Description and Business Overview

6.1.3 Novo Nordisk Long-acting Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Novo Nordisk Long-acting Weight Loss Drugs Product Portfolio

6.1.5 Novo Nordisk Recent Developments/Updates

6.2 Roche

6.2.1 Roche Company Information

6.2.2 Roche Description and Business Overview

6.2.3 Roche Long-acting Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Roche Long-acting Weight Loss Drugs Product Portfolio

6.2.5 Roche Recent Developments/Updates

6.3 GSK

6.3.1 GSK Company Information

6.3.2 GSK Description and Business Overview

6.3.3 GSK Long-acting Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 GSK Long-acting Weight Loss Drugs Product Portfolio

6.3.5 GSK Recent Developments/Updates

6.4 Vivus

6.4.1 Vivus Company Information

6.4.2 Vivus Description and Business Overview

6.4.3 Vivus Long-acting Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Vivus Long-acting Weight Loss Drugs Product Portfolio

6.4.5 Vivus Recent Developments/Updates

6.5 Arena

6.5.1 Arena Company Information

6.5.2 Arena Description and Business Overview

6.5.3 Arena Long-acting Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Arena Long-acting Weight Loss Drugs Product Portfolio

6.5.5 Arena Recent Developments/Updates

6.6 Orexigen

6.6.1 Orexigen Company Information

6.6.2 Orexigen Description and Business Overview

6.6.3 Orexigen Long-acting Weight Loss Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Orexigen Long-acting Weight Loss Drugs Product Portfolio

6.6.5 Orexigen Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Long-acting Weight Loss Drugs Industry Chain Analysis

7.2 Long-acting Weight Loss Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Long-acting Weight Loss Drugs Production Mode & Process Analysis

7.4 Long-acting Weight Loss Drugs Sales and Marketing

7.4.1 Long-acting Weight Loss Drugs Sales Channels

7.4.2 Long-acting Weight Loss Drugs Distributors

7.5 Long-acting Weight Loss Drugs Customer Analysis

8 Long-acting Weight Loss Drugs Market Dynamics

8.1 Long-acting Weight Loss Drugs Industry Trends

8.2 Long-acting Weight Loss Drugs Market Drivers

8.3 Long-acting Weight Loss Drugs Market Challenges

8.4 Long-acting Weight Loss Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Novo Nordisk

Roche

GSK

VIVUS

Arena

Orexigen

List of Tables

Table 1. Global Long-acting Weight Loss Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Long-acting Weight Loss Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Long-acting Weight Loss Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Long-acting Weight Loss Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Long-acting Weight Loss Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Long-acting Weight Loss Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Long-acting Weight Loss Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Long-acting Weight Loss Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Long-acting Weight Loss Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Long-acting Weight Loss Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Long-acting Weight Loss Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Long-acting Weight Loss Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Long-acting Weight Loss Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Weight Loss Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Long-acting Weight Loss Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Long-acting Weight Loss Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Long-acting Weight Loss Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Long-acting Weight Loss Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Long-acting Weight Loss Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Long-acting Weight Loss Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Long-acting Weight Loss Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Long-acting Weight Loss Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Long-acting Weight Loss Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Long-acting Weight Loss Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Long-acting Weight Loss Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Long-acting Weight Loss Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Long-acting Weight Loss Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Long-acting Weight Loss Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Long-acting Weight Loss Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Long-acting Weight Loss Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Long-acting Weight Loss Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Long-acting Weight Loss Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Long-acting Weight Loss Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Long-acting Weight Loss Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Long-acting Weight Loss Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Long-acting Weight Loss Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Long-acting Weight Loss Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Long-acting Weight Loss Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Long-acting Weight Loss Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Long-acting Weight Loss Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Long-acting Weight Loss Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Long-acting Weight Loss Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Long-acting Weight Loss Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Long-acting Weight Loss Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Long-acting Weight Loss Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Long-acting Weight Loss Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Long-acting Weight Loss Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Long-acting Weight Loss Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Long-acting Weight Loss Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Long-acting Weight Loss Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Long-acting Weight Loss Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Long-acting Weight Loss Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Long-acting Weight Loss Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Long-acting Weight Loss Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Long-acting Weight Loss Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Long-acting Weight Loss Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Long-acting Weight Loss Drugs Price (US$/Unit) by Type (2020-2025)

Table 59. Global Long-acting Weight Loss Drugs Price (US$/Unit) by Type (2026-2031)

Table 60. Global Long-acting Weight Loss Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Long-acting Weight Loss Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Long-acting Weight Loss Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Long-acting Weight Loss Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Long-acting Weight Loss Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Long-acting Weight Loss Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Long-acting Weight Loss Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Long-acting Weight Loss Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Long-acting Weight Loss Drugs Price (US$/Unit) by Application (2020-2025)

Table 69. Global Long-acting Weight Loss Drugs Price (US$/Unit) by Application (2026-2031)

Table 70. Novo Nordisk Company Information

Table 71. Novo Nordisk Description and Business Overview

Table 72. Novo Nordisk Long-acting Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Novo Nordisk Long-acting Weight Loss Drugs Product

Table 74. Novo Nordisk Recent Developments/Updates

Table 75. Roche Company Information

Table 76. Roche Description and Business Overview

Table 77. Roche Long-acting Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Roche Long-acting Weight Loss Drugs Product

Table 79. Roche Recent Developments/Updates

Table 80. GSK Company Information

Table 81. GSK Description and Business Overview

Table 82. GSK Long-acting Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. GSK Long-acting Weight Loss Drugs Product

Table 84. GSK Recent Developments/Updates

Table 85. Vivus Company Information

Table 86. Vivus Description and Business Overview

Table 87. Vivus Long-acting Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Vivus Long-acting Weight Loss Drugs Product

Table 89. Vivus Recent Developments/Updates

Table 90. Arena Company Information

Table 91. Arena Description and Business Overview

Table 92. Arena Long-acting Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Arena Long-acting Weight Loss Drugs Product

Table 94. Arena Recent Developments/Updates

Table 95. Orexigen Company Information

Table 96. Orexigen Description and Business Overview

Table 97. Orexigen Long-acting Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Orexigen Long-acting Weight Loss Drugs Product

Table 99. Orexigen Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Long-acting Weight Loss Drugs Distributors List

Table 103. Long-acting Weight Loss Drugs Customers List

Table 104. Long-acting Weight Loss Drugs Market Trends

Table 105. Long-acting Weight Loss Drugs Market Drivers

Table 106. Long-acting Weight Loss Drugs Market Challenges

Table 107. Long-acting Weight Loss Drugs Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Long-acting Weight Loss Drugs

Figure 2. Global Long-acting Weight Loss Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Long-acting Weight Loss Drugs Market Share by Type: 2024 & 2031

Figure 4. Orlistat Product Picture

Figure 5. Semaglutide Product Picture

Figure 6. Liraglutide Product Picture

Figure 7. Other Product Picture

Figure 8. Global Long-acting Weight Loss Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Long-acting Weight Loss Drugs Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Other

Figure 13. Global Long-acting Weight Loss Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Long-acting Weight Loss Drugs Market Size (2020-2031) & (US$ Million)

Figure 15. Global Long-acting Weight Loss Drugs Sales (2020-2031) & (K Units)

Figure 16. Global Long-acting Weight Loss Drugs Average Price (US$/Unit) & (2020-2031)

Figure 17. Long-acting Weight Loss Drugs Report Years Considered

Figure 18. Long-acting Weight Loss Drugs Sales Share by Manufacturers in 2024

Figure 19. Global Long-acting Weight Loss Drugs Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Long-acting Weight Loss Drugs Players: Market Share by Revenue in Long-acting Weight Loss Drugs in 2024

Figure 21. Long-acting Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Long-acting Weight Loss Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Long-acting Weight Loss Drugs Sales Market Share by Country (2020-2031)

Figure 24. North America Long-acting Weight Loss Drugs Revenue Market Share by Country (2020-2031)

Figure 25. United States Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Long-acting Weight Loss Drugs Sales Market Share by Country (2020-2031)

Figure 28. Europe Long-acting Weight Loss Drugs Revenue Market Share by Country (2020-2031)

Figure 29. Germany Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Long-acting Weight Loss Drugs Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Long-acting Weight Loss Drugs Revenue Market Share by Region (2020-2031)

Figure 36. China Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Southeast Asia Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Long-acting Weight Loss Drugs Sales Market Share by Country (2020-2031)

Figure 44. Latin America Long-acting Weight Loss Drugs Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Colombia Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Long-acting Weight Loss Drugs Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Long-acting Weight Loss Drugs Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Long-acting Weight Loss Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Long-acting Weight Loss Drugs by Type (2020-2031)

Figure 55. Global Revenue Market Share of Long-acting Weight Loss Drugs by Type (2020-2031)

Figure 56. Global Long-acting Weight Loss Drugs Price (US$/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Long-acting Weight Loss Drugs by Application (2020-2031)

Figure 58. Global Revenue Market Share of Long-acting Weight Loss Drugs by Application (2020-2031)

Figure 59. Global Long-acting Weight Loss Drugs Price (US$/Unit) by Application (2020-2031)

Figure 60. Long-acting Weight Loss Drugs Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Anti Obesity Drugs Anti obesity Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Weight Control Medication Market Research Report 2024

Global Prescription Weight Loss Pills Market Research Report 2024

Global Oral Anorexiant Drug Market Research Report 2024

Global GLP 1 Weight Loss Drug Market Research Report 2024

Global Sustained release Medicine Market Research Report 2025

Global GLP 1 Weight Loss Pill Market Research Report 2024

Global Diet Pill Market Insights Forecast to 2030

Global Long acting Anti HIV Drugs Market Research Report 2024

Global Weight Loss Medicine Orlistat Market Research Report 2024

Global Long Acting Contraceptive Pills Market Research Report 2024

Global Long acting GLP 1RA Market Research Report 2024

Global Weight Control Products Market Insights Forecast to 2030

Global Ultra Long acting GLP 1RA Market Research Report 2024

Global Weight Loss Therapeutics Market Insights Forecast to 2030

Global Prescription Weight Loss Medications Market Research Report 2025

Global Long acting EPO Drugs Market Research Report 2024

Global Weight loss Drugs Market Insights Forecast to 2030

Long acting Injectable Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions